Top 15 der gesamten Suchanfragen der letzten 7 Tage

Push-Kurse

CytomX Therapeutics Aktie

Aktie

ISIN: US23284F1057 WKN: A14158 SYM: 6C1 Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

2,5200

EUR

-3,82 %

-0,1000 EUR

Letzter Kurs 16.06.26 Tradegate

CytomX Therapeutics Aktie kaufen

Geldkurs

11:42:39

2,5170

EUR

2.000 STK

Briefkurs

11:42:39

2,6180

EUR

1.942 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Mo-Fr von 07:30 bis 23:00 Uhr
Neu: Samstag von 14:00 bis 19:00 Uhr

Nachrichten zu CytomX Therapeutics

Neueste Meldungen

CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer Englische Nachricht

CytomX Therapeutics to Present at Upcoming June Investor Conferences Englische Nachricht

Artikel in Nachrichten zu CytomX Therapeutics

Neueste
Meistgelesene

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs 18.05.26 · globenewswire

30 Tage
6 Monate

CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer 03.06.26 · globenewswire · 188 Leser
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs 18.05.26 · globenewswire · 152 Leser
CytomX Therapeutics to Present at Upcoming June Investor Conferences 21.05.26 · globenewswire · 120 Leser

Fokus Aktien mit extremen Handelsvolumen am Mittwoch, den 15.04.2026 15.04.26 · wO Chartvergleich · 960 Leser
CytomX Therapeutics Announces Business Update and Company Milestones for 2026 08.01.26 · globenewswire · 252 Leser
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer 03.06.26 · globenewswire · 188 Leser
CytomX Therapeutics to Present at Upcoming February Conferences 04.02.26 · globenewswire · 184 Leser
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 04.03.26 · globenewswire · 184 Leser
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants 18.03.26 · globenewswire · 184 Leser
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants 16.03.26 · globenewswire · 180 Leser
CytomX’s Varsetatug Masetecan (EpCAM PROBODY ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer 16.03.26 · globenewswire · 168 Leser
CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update 16.03.26 · globenewswire · 168 Leser
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs 18.05.26 · globenewswire · 152 Leser

CytomX Therapeutics News

CytomX Therapeutics News: Auf dieser Seite finden Sie alle CytomX Therapeutics News und Nachrichten zur CytomX Therapeutics Aktie. Dies beinhaltet die Agenturmeldungen auf wallstreet-online.de, aber auch CytomX Therapeutics News von einer Vielzahl an Gastautoren, Partnern und Analysten.